Target intelligence / Profile preview

NAD-dependent histone deacetylase SIR2 (Sir2p) (Sir2p)

Target
Sir2p
Molecular classification
Enzyme, Histone modification, Sirtuin, NAD-dependent deacetylase
01

Overview

Yeast Sir2p (Silent Information Regulator 2) is the founding member of the sirtuin family of NAD+-dependent protein deacetylases (UniProt [1]). It is primarily known for its role in gene silencing at the silent mating-type loci, telomeres, and ribosomal DNA (rDNA) in Saccharomyces cerevisiae (PMC [6]). By deacetylating lysine residues on histones, particularly H4K16, Sir2p promotes the formation of repressive heterochromatin and suppresses unequal recombination within the rDNA repeats (PMC [7]). This suppression of recombination is a major factor in determining the replicative lifespan of yeast cells, as it prevents the formation of toxic extrachromosomal rDNA circles (PubMed [12]). Sir2p also acts as a metabolic sensor, linking the availability of NAD+ to the regulation of aging and stress responses, particularly during calorie restriction (PMC [14]). In addition to its role in yeast biology, Sir2p serves as a critical model for understanding human sirtuins like SIRT1, which are implicated in age-related diseases and cancer (PMC [13]). Small molecules such as resveratrol have been identified as activators of Sir2p, while compounds like splitomicin and nicotinamide act as potent inhibitors (PMC [8], PMC [9]). Research into Sir2p continues to provide insights into the epigenetic mechanisms of longevity and the potential for therapeutic intervention in metabolic and degenerative disorders (NCBI [10]).

Other names
Silent information regulator 2Regulatory protein SIR2Sirtuin 2MAR1
02

Mechanism of action

NAD+-dependent deacetylation of lysine residues on histones and other proteins, coupled with the hydrolysis of NAD+ to produce nicotinamide and O-acetyl-ADP-ribose (UniProt [1], PMC [7]).

03

Biological functions

Gene silencingAgingDNA repairChromatin remodelingRecombination suppression
04

Disease associations

AgingCancerInfection
05

Safety considerations

Genomic instabilityMetabolic disruptionOff-target sirtuin inhibition
06

Interacting drugs

Resveratrol

4 more in the full profile.

07

Biomarkers

Histone H4K16 acetylationrDNA recombination rateReplicative lifespanExtrachromosomal rDNA circles

Beyond the preview

Go deeper on NAD-dependent histone deacetylase SIR2 (Sir2p) (Sir2p).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NAD-dependent histone deacetylase SIR2 (Sir2p) (Sir2p).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call